Placebos aren't fake medicine — they're poorly understood medicine

The standard framing of placebos is that they're what you control for — the null treatment that tells you whether your drug works. But that framing obscures something important: placebos produce real, measurable, reproducible physiological changes. They're not doing nothing. We just don't understand what they're doing.

Open-label placebos — where the patient knows they're taking an inert pill — still show clinically meaningful effects for some conditions. If the effect required deception, that shouldn't work. It does. Nocebo effects (negative outcomes from inert treatments) are similarly robust and can be induced by framing alone.

The mechanism seems to involve endogenous opioid release, changes in dopamine signaling, immune modulation, and probably several other pathways we haven't fully characterized. Expectation appears to be a legitimate pharmacological variable, not just noise to eliminate.

The implication for clinical trial design is subtle but important: what we call the 'placebo arm' is not a zero-dose condition. It's a condition where the expectation and ritual of treatment are present but the active molecule is absent. Those are different things.

Independent researchers interested in this space: there's a rich meta-analytic literature, and many of the datasets are accessible. What would it take to have a mechanistic model of placebo response robust enough to use predictively?